2022
DOI: 10.1007/s43465-022-00689-2
|View full text |Cite
|
Sign up to set email alerts
|

Resection of Osteoid Osteoma Using Three-Dimensional (3D) Printing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…In the biomedical domain, 3D printing has established itself as a versatile technology with diverse applications including, but not limited to, regenerative medicine, [27][28][29] microneedle-based drug/vaccine patches, [30][31][32][33] flexible bioelectronics, [34][35][36] biohybrid actuators, [37][38][39] customized implants and prosthetics, [40][41][42][43] and specialized surgical tools. [44][45][46] 3D bioprinting has received widespread attention owing to its robust capabilities in recapitulating biomimetic tissue constructs for regenerative medicine, [47][48][49][50][51] as well as for developing organotypic models for toxicology, disease modeling, and drug discovery. [52][53][54][55] Nonetheless, questions persist regarding the requisite threshold of complexity necessary to faithfully emulate the functional characteristics of native tissues within engineered constructs.…”
Section: Introductionmentioning
confidence: 99%
“…In the biomedical domain, 3D printing has established itself as a versatile technology with diverse applications including, but not limited to, regenerative medicine, [27][28][29] microneedle-based drug/vaccine patches, [30][31][32][33] flexible bioelectronics, [34][35][36] biohybrid actuators, [37][38][39] customized implants and prosthetics, [40][41][42][43] and specialized surgical tools. [44][45][46] 3D bioprinting has received widespread attention owing to its robust capabilities in recapitulating biomimetic tissue constructs for regenerative medicine, [47][48][49][50][51] as well as for developing organotypic models for toxicology, disease modeling, and drug discovery. [52][53][54][55] Nonetheless, questions persist regarding the requisite threshold of complexity necessary to faithfully emulate the functional characteristics of native tissues within engineered constructs.…”
Section: Introductionmentioning
confidence: 99%